CELV OTC
Cellev8 Nutrition Inc.
1W: +59.0%
1M: +194.1%
3M: +260.0%
YTD: +71.4%
1Y: -0.7%
3Y: +260.0%
5Y: -34.5%
$0.18
+0.00 (+0.00%)
Weekly Expected Move ±59.7%
$-0
$0
$0
$0
$0
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Income Trends
Revenue
$284K
+42.8% ▲
5Y CAGR: +23.7%
Gross Profit
-$179K
+40.5% ▲
Operating Income
-$1M
-22.7% ▼
Net Income
-$2M
-701.1% ▼
EPS (Diluted)
$-0.01
-636.4% ▼
EBITDA
-$1M
-483.2% ▼
Profit Margins
Year-over-Year Growth
View Full Income Statement
| Line Item | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Revenue | $19K | $31K | $235K | $199K | $284K |
| YoY Growth | -81.1% | +67.5% | +653.6% | -15.3% | +42.8% |
| Cost of Revenue | $12K | $20K | $102K | $500K | $463K |
| Gross Profit | $7K | $11K | $133K | -$301K | -$179K |
| Gross Margin | 35.7% | 36.4% | 56.7% | -151.5% | -63.1% |
| R&D Expenses | $0 | $0 | $0 | $0 | $0 |
| SG&A Expenses | $460K | $378K | $765K | $918K | $1M |
| Operating Expenses | $460K | $378K | $765K | $918K | $1M |
| Operating Income | -$454K | -$367K | -$632K | -$1M | -$1M |
| Operating Margin | -2441.3% | -1177.5% | -269.2% | -613.1% | -526.8% |
| Interest Expense | $117K | $122K | $93K | $122K | $92K |
| Income Before Tax | -$573K | -$488K | -$725K | $264K | -$2M |
| Tax Expense | $0 | $0 | $0 | $0 | $0 |
| Net Income | -$573K | -$488K | -$725K | $264K | -$2M |
| Net Margin | -3081.0% | -1568.5% | -309.1% | 132.8% | -559.1% |
| EPS (Diluted) | $-0.01 | $-0.00 | $-0.01 | $0.00 | $-0.01 |
| EBITDA | -$451K | -$361K | -$626K | $390K | -$1M |
| Shares Outstanding | 96M | 103M | 112M | 120M | 134M |